Before you sell to, join or invest in Ausel, Inc.
MentionFox check on Ausel, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/ausel-inc-form-d-000001
Check Ausel, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Ausel, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Ausel, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-04.
Ausel, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 4, 2026. The filing reports $120K sold. Its industry group is Biotechnology. It names Nicholas Ainslie (Chief Executive Officer and Chief Financial Officer), Paul Shockley (Chief Operating Officer and Secretary), Prisco Piscitelli (Chief Medical Officer) (SEC Form D, November 4, 2026).
Ausel, Inc. raised on Nov 4. 125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Ausel, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Ausel, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Ausel, Inc.
Free to see. No signup.
More on the people and the money behind Ausel, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed within 90 days of this one, largest first.
Get an email when Ausel, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Ausel, Inc. raises, hires or launches. No email unless you switch it on.
Watch Ausel, Inc. →Get the full cited report on Ausel, Inc.
What the filing shows about Ausel, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ausel, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Ausel, Inc.'s address as 2871 Rancho Cortes, Carlsbad, CA 92009.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Ausel, Inc. is a registered filer with the SEC (CIK 2124022) and has filed since 2026-11-04. 1 filing is on record, the latest on 2026-11-04.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Ausel, Inc.'s Form D of 2026-11-04 names Nicholas Ainslie, Paul Shockley, Prisco Piscitelli and 2 more as its officers, directors or promoters.
Its new offerings report $120K sold across 1 offering, as its own filings state.
Trailing twelve months. 765 filings in Biotechnology, totalled by week. The dot is this raise, $120K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Represents potential repayment of non-interest-bearing loans made by certain officers, directors, and a promoter, as disclosed in the offering memorandum. Repayment timing has not been determined and is subject to Class A Preferred approval.
On the filing as: Executive Officer, Director.
Nicholas Ainslie is named as Chief Executive Officer and Chief Financial Officer on the Form D that Ausel, Inc. filed with the SEC on 4 November 2026, one of 5 people that filing names.
On the filing as: Executive Officer, Director.
Paul Shockley is named as Chief Operating Officer and Secretary on the Form D that Ausel, Inc. filed with the SEC on 4 November 2026, one of 5 people that filing names.
On the filing as: Executive Officer.
Prisco Piscitelli is named as Chief Medical Officer on the Form D that Ausel, Inc. filed with the SEC on 4 November 2026, one of 5 people that filing names.
On the filing as: Director.
Paul Ainslie is named as Chairman of the Board of Directors on the Form D that Ausel, Inc. filed with the SEC on 4 November 2026, one of 5 people that filing names.
On the filing as: Promoter.
Robert Ainslie is named as Non-operating founder on the Form D that Ausel, Inc. filed with the SEC on 4 November 2026, one of 5 people that filing names.
5 people named on the filing — 3 holding an executive role, 1 as a director only and 1 named in another capacity.
Named as of the 2026-11-04 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Ausel, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ausel, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ausel, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Ausel, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Ausel, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Ausel, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-11-02 · Biotech raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ausel-inc-form-d-000001